Eli Lilly and Company (NYSE: LLY), a leading pharmaceutical corporation in the U.S., has announced that Huzur Devletsah has officially assumed the role of president and general manager of its China operations, marking a historic moment as she becomes the first female leader of the unit.
Huzur Devletsah’s journey with Lilly began in 1998, and since then, she has accumulated a wealth of experience across various geographies and roles. She has served as president and general manager for Lilly in Italy, as well as in the Central and Eastern Europe and Commonwealth of Independent States of Russia regions. Her tenure also includes a period as the managing director of the Middle East for the company.
In addition to these roles, Huzur Devletsah has held the position of senior director of strategy and operations for Eli Lilly Biomedical and has led as the head of the international diabetes business unit. Her responsibilities have spanned a broad range of critical functions, including sales, marketing, strategic planning, business expansion, market access, and public affairs, among others.- Flcube.com
